Eric A. Adams
Net Worth
Last updated:
What is Eric A. Adams net worth?
The estimated net worth of Mr. Eric A. Adams is at least $2,541,108 as of 20 Feb 2024. He owns shares worth $98,908 as insider and has received compensation worth at least $2,442,200 in InMed Pharmaceuticals Inc. and InMed Pharmaceuticals Inc..
What is the salary of Eric A. Adams?
Mr. Eric A. Adams salary is $488,440 per year as Pres, Chief Executive Officer & Director in InMed Pharmaceuticals Inc.. He also receives $488,440 as Pres, Chief Executive Officer & Director in InMed Pharmaceuticals Inc..
How old is Eric A. Adams?
Mr. Eric A. Adams is 61 years old, born in 1964.
What stocks does Eric A. Adams currently own?
As insider, Mr. Eric A. Adams owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | Pres, Chief Executive Officer & Director | 43,959 | $2.25 | $98,908 |
What does InMed Pharmaceuticals Inc. do?
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Eric A. Adams insider trading
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals key executives
InMed Pharmaceuticals Inc. executives and other stock owners filed with the SEC:
- Mr. Bruce S. Colwill C.A., CPA, CA (60) Chief Financial Officer & Corporation Sec.
- Mr. Eric A. Adams (61) Pres, Chief Executive Officer & Director
- Ms. Alexandra Diane-Janet Mancini (72) Senior Vice President of Clinical & Regulatory Affairs